J. William Freytag, Ph.D., President & CEO Of Myogen To Be Special Guest At 14th Annual Biotech Investing Conference

Published: Oct 26, 2006

NEW YORK, NY -- (MARKET WIRE) -- October 26, 2006 -- IBF Conferences, Inc. and SRI International today announced that J. William Freytag, Ph.D., President & CEO of Myogen, will be a special guest at the 14th Annual Biotech Investing Conference held at SRI International at Menlo Park, CA.

Back to news